Abstract
As clinicians’ knowledge about the relationship between inflammatory bowel diseases (IBDs) and the integumentary system continues to expand, gastroenterologists and dermatologists need to know about the disease associations involved and understand the impact of treatments on these immune conditions in order to provide care to these medically complex patients.